Cannabinol - Amerigo Scientific

- Overview
  - Please contact us at for specific academic pricing.
- Properties
  - Categories
    
    Ligands of GPCRs
    
    Alternative Name
    
    6,6,9-Trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol; 3-Amyl-1-hydroxy-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; 6,6,9-Trimethyl-3-pentyl-6H -dibenzo[b,d]pyran-1-ol
    
    CAS Number
    
    521-35-7
    
    Molecular Formula
    
    C21H26O2
    
    Molecular Weight
    
    310.43 g/mol
    
    MDL Number
    
    MFCD00056774
    
    Note
    
    There is no hazardous surcharge associated with this product.
    There is no special packaging charge associated with this product.
    
    * For research use only. Not for human or veterinary use
- Reference
  - Yea et al (2000). Role of nuclear factor of activated T-cells and activator protein-1 in the inhibition of interleukin-2 gene transcription by cannabinol in EL4 T-cells. The Journal of pharmacology and experimental therapeutics, 292(2):597–605.
    Munson et al (1975). Antineoplastic Activity of Cannabinoids. JNCI: Journal of the National Cancer Institute, 55(3):597-60.
    Zygmunt et al (2002). Delta 9-tetrahydrocannabinol and cannabinol activate capsaicin-sensitive sensory nerves via a CB1 and CB2 cannabinoid receptor-independent mechanism. The Journal of Neuroscience, 22(11):4720–4727.